|
CN111471020A
|
|
Preparation method of apltinib intermediate
|
|
CN111470946A
|
|
Preparation method of 2-ethyl-1-butanol serving as midbody of Reidesciclovir
|
|
CN109384747A
|
|
Gefitinib related substances and its preparation and detection method
|
|
CN107445879A
|
|
Draw the bent preparation method for replacing Buddhist nun's intermediate
|
|
CN107188887A
|
|
A kind of AMN107 oxidative degradation impurity and preparation method thereof
|
|
CN106220634A
|
|
Related substances F and G of pemetrexed disodium and preparation thereof and detection method
|
|
CN107628982A
|
|
Bazedoxifene acetate polymorphic A preparation method
|
|
CN105130998A
|
|
Preparation method for copanlisib
|
|
CN105061467A
|
|
Method for preparing pacritinib
|
|
CN104926734A
|
|
Preparation method of flibanserin
|
|
CN103772261A
|
|
Preparation method of bazedoxifene
|
|
CN103772295A
|
|
Preparation method of Ticagrelor intermediate 4,6-dichloro-2-(mercaptopropionic)-5-aminopyrimidine
|
|
CN103694176A
|
|
Preparation method of nilotinib intermediate
|
|
CN103396326A
|
|
Preparation method of ritodrine hydrochloride
|
|
CN103412064A
|
|
Method for detecting impurities of DL-2-Chlorophenylglycine through high performance liquid chromatograph
|
|
CN103275005A
|
|
Preparation method for ent-3-methoxy-17-methyl dromoran-10 ketone
|
|
CN103265489A
|
|
Preparation method of ent-(14S)-3-methoxyl-17-morphinan
|
|
CN103275020A
|
|
Erlotinib preparation method
|
|
CN103159685A
|
|
Preparation method of 4-chloro-6, 7-di(2-methoxyl ethoxyl) quinazoline
|
|
CN103113239A
|
|
Preparation method of ritodrine hydrochloride
|
